Outcomes and quality of life in patients receiving durable left ventricular assist device with biventricular support.
Amit IyengarNoah WeingartenCindy SongDavid RekhtmanMax ShinMark R HelmersJoyce WaldMarisa CevascoPavan AtluriPublished in: Artificial organs (2024)
Patients requiring BIVAD therapy have more advanced shock, longer associated hospital courses, and lower long-term survival. However, those that survive enjoy similar overall quality of life, and many endorse positive outlooks on their surgical course. Continued assessments of quality of life are important in providing patient-centered LVAD care.
Keyphrases
- left ventricular assist device
- healthcare
- end stage renal disease
- newly diagnosed
- ejection fraction
- palliative care
- prognostic factors
- peritoneal dialysis
- emergency department
- stem cells
- heart failure
- metabolic syndrome
- patient reported outcomes
- type diabetes
- left ventricular
- adverse drug
- patient reported
- cardiac resynchronization therapy
- electronic health record
- chronic pain
- health insurance